Current Report
Filed: 2026-01-09
Key Insights
- Athira Pharma, Inc. has changed its name to LeonaBio, Inc. and updated its ticker symbol to LONA, potentially signaling a strategic shift for the company.
- The company has entered into an amended change in control and severance agreement with its Chief Financial Officer, Robert Renninger, providing additional protections in the event of his termination.
- LeonaBio has launched a new corporate website at www.leonabio.com, where investors can find the company's SEC filings, press releases, and other investor relations information.